stock.name

10x Genomics Inc - Ordinary Shares - Class A

TXG

Market Cap$3.99B
Close$

Compare 10x Genomics- Ordinary Shares

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
10x Genomics Inc - Ordinary Shares - Class A10x Genomics Inc - Ordinary Shares - Class A-15.70%-34%7.4-
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$42.10

Current Fair Value

14.1% upside

Undervalued by 14.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.99 Billion
Enterprise Value$3.61 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-2.18
Beta2.07
Outstanding Shares105,109,711
Avg 30 Day Volume1,316,572

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-15.66
PEG-8.49
Price to Sales7.38
Price to Book Ratio5.27
Enterprise Value to Revenue5.83
Enterprise Value to EBIT-17.64
Enterprise Value to Net Income-15
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About 10x Genomics Inc

CEO: Serge Saxonov